Investor Presentaiton

Substantial Growth Opportunities ~$2.5B¹ TAM AROA™ Wound Care Endoform™ Symphony™ Proliferative Bioscaffold Antimicrobial Restorative Bioscaffold Endoform™ Natural Restorative Bioscaffold Myriad Matrix™ Soft Tissue Bioscaffold Soft Tissue Reconstruction Myriad Morcells Morcellized Bioscaffold TELA BIO SURGICAL RECONSTRUCTION COMPANY SCIENCE. VALUE. INNOVATION. I OVITEX REINFORCED TISSUE MATRIX OVITEX PRS REINFORCED TISSUE MATRIX Total Addressable Market $1.4B1 USD e.g. Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, chronic wounds e.g. Trauma, tumour removal, general surgery, inflammatory skin disease Total Addressable Market $1.3B² USD e.g. Hernia repair, abdominal dehiscence, breast surgery 1. SmartTRAK BiomedGPS data 2020. AROA management estimates; 2. DRG Millennium Research data; Hernia Repair Devices, 2020. DRG Millennium Research, Breast Implants & Reconstructive devices, 2018. AROA TM

View entire presentation